| ID Source | ID |
|---|---|
| PubMed CID | 6827 |
| CHEMBL ID | 2104644 |
| CHEBI ID | 135264 |
| SCHEMBL ID | 554391 |
| MeSH ID | M0073757 |
| Synonym |
|---|
| nsc-408889 |
| chemestrogen |
| nsc408889 |
| benzestrol |
| CHEBI:135264 |
| 4-[3-ethyl-4-(4-hydroxyphenyl)hexan-2-yl]phenol |
| FT-0662567 |
| 85-95-0 |
| ocestrol |
| CHEMBL2104644 |
| benzestrol [usp:inn:ban] |
| benzoestrolum |
| benzestrolo |
| 4,4'-(1,2-diethyl-3-methyl-1,3-propanediyl)bisphenol |
| phenol, 4,4'-(1,2-diethyl-3-methyl-1,3-propanediyl)bis- |
| ai3-23191 |
| 4,4'-(1,2-diethyl-3-methyltrimethylene)diphenol |
| benzestrolum |
| octoestrolum |
| unii-a27512lr47 |
| a27512lr47 , |
| benzestrolum [inn-latin] |
| benzestrolo [dcit] |
| octofollin |
| benzoestrol |
| benzestrol [mart.] |
| benzestrol [inn] |
| benzestrol [mi] |
| SCHEMBL554391 |
| DUTFBSAKKUNBAL-UHFFFAOYSA-N |
| AKOS030254537 |
| Q4890763 |
| 4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-sulfonylchloride |
| DTXSID50861663 |
| 4,4'-(3-ethylhexane-2,4-diyl)diphenol |
| Class | Description |
|---|---|
| phenylpropanoid | Any organic aromatic compound with a structure based on a phenylpropane skeleton. The class includes naturally occurring phenylpropanoid esters, flavonoids, anthocyanins, coumarins and many small phenolic molecules as well as their semi-synthetic and synthetic analogues. Phenylpropanoids are also precursors of lignin. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 6 (85.71) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (12.50%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 7 (87.50%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||